[Problems of directed hemostasis and coagulation stimulation in pathological tendency to bleed].
D000614:Aminocaproates / Q000008:administration & dosage; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D007611:Aprotinin / Q000008:administration & dosage; D001565:Benzoates / Q000008:administration & dosage; D001777:Blood Coagulation / Q000187:drug effects*; D001792:Blood Platelets / Q000502:physiology; D002118:Calcium / Q000097:blood; D003348:Cortisone / Q000008:administration & dosage; D004837:Epinephrine / Q000008:administration & dosage; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D009119:Muscle Contraction; D009130:Muscle, Smooth; D011517:Prothrombin Time; D013917:Thrombin / Q000032:analysis; D013927:Thrombosis / Q000503:physiopathology; D014805:Vitamin B 12 / Q000008:administration & dosage
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D001565:Benzoates; D005337:Fibrin; D005340:Fibrinogen; D007611:Aprotinin; D013917:Thrombin; D014805:Vitamin B 12; D002118:Calcium; D003348:Cortisone; D004837:Epinephrine
Die Problematik einer gezielten medikamentösen Blutstillung und Gerinnungsförderung bei pathologischer Blutungsneigung.